Search

The FDA has approved the targeted drug repotrectinib for patients 12 and older with tumors that carry gene changes called NTRK fusions. The trial that resulted in the approval was led by MSK investigators.

… Thursday, June 13, 2024 On June 13, 2024, a targeted drug called  repotrectinib (Augtyro TM ) received accelerated approval from the US Food and Drug Administration (FDA) for treating cancers caused by gene changes called  NTRK fusions. The clinical trial that resulted in the approval was led globally

A prostate-specific antigen (PSA) test taken for the first time between the ages of 44 and 50 can predict the likelihood that a man will die from prostate cancer over the next 25 to 30 years, according to researchers at Memorial Sloan Kettering Cancer Center.

… Thursday, May 19, 2011 A prostate-specific antigen (PSA) test taken for the first time between the ages of 44 and 50 can predict the likelihood that a man will die from prostate cancer over the next 25 to 30 years, according to researchers at Memorial Sloan Kettering Cancer Center. The findings, which

Pituitary adenomas continue to grow in a small subset of patients despite treatment with standard surgery and radiotherapy. Recognizing the significant unmet needs in this cohort, we recently published a review of the latest treatment options.

… Wednesday, October 14, 2020 Pituitary adenomas continue to grow in a small subset of patients despite treatment with standard surgery and radiotherapy. Further treatments may provide symptom relief but are rarely definitive for disease management in this cohort. Recognizing the significant unmet needs

Several Memorial Sloan Kettering investigators are focused on the study of bacteria, which can teach us much about human health, and about cancer in particular.

… Tuesday, April 1, 2014 Summary Several Memorial Sloan Kettering investigators are focused on the study of bacteria, which can teach us much about human health, and about cancer in particular. At first glance, tiny single-celled bacteria could not be more different from humans. But there are many reasons

Degrees were presented and awards were given at the 38th annual ceremony held on May 18.

… Monday, May 22, 2017 Joan Massagué Sloan Kettering Institute Director Joan Massagué Yu Chen and Amanda Roxanne Moore Physician-scientist Yu Chen with graduate Amanda Roxanne Moore José Baselga, Charles Sawyers, and Andrew Kung Physician-in-Chief José Baselga, Human Oncology and Pathogenesis Program Chair

By blocking a source of inflammation in the skin, it may be possible to prevent or treat lymphedema, a common and debilitating cancer complication.

… Wednesday, February 15, 2017 Summary Mounting evidence implicates inflammation as a cause of lymphedema, a common side effect of cancer treatment. Topical drugs that suppress this inflammation may hold promise as a therapy. Highlights Previous research has shown that immune cells promote the inflammation

Since its inception at MSK 10 years ago, the Immigrant Health and Cancer Disparities (IHCD) Service has made significant progress in addressing barriers to access to cancer treatment and other healthcare for underserved communities across New York City and beyond.

… Monday, April 26, 2021 Since its inception at Memorial Sloan Kettering Cancer Center 10 years ago, the Immigrant Health and Cancer Disparities (IHCD) Service has made significant progress in addressing barriers to access to cancer treatment and other healthcare for underserved communities across New

Dr. Diane Reidy-Lagunes discusses cannabis and cancer with MSK’s Director of Pediatric Integrated Medicine, Dr. Nirupa Raghunathan, and cancer survivor and winner of TV’s “Survivor: Africa”, Ethan Zohn.

… Wednesday, May 4, 2022 Cannabis is an ancient plant that has been used for rituals and medicine for 5,000 years. People with cancer have turned to cannabis — better known as weed or marijuana — to relieve effects of both the illness and the treatment. Because of its ever-changing legal status, studies

Learn how a new treatment approach using high-dose radiation has given hope to people with inoperable tumors.

… Tuesday, October 2, 2018 Summary People with  liver cancer  or  pancreatic cancer sometimes have tumors that are too large to be removed through surgery. Conventional radiation doses are not able to control these tumors. A new radiation approach using higher doses can sometimes control large tumors in

Meet Dario Cortes, who was treated for rectal cancer at Memorial Sloan Kettering and is now back to doing the activities he loves.

… Tuesday, December 18, 2018 VIDEO | 01:02 The stages of colon cancer Video Details Summary Dario Cortes was diagnosed with rectal cancer in 2015. He started chemotherapy and radiation at Memorial Sloan Kettering and had no evidence of disease when he finished treatment. When the cancer returned six months